Influence of Stent Parameters and Post-Stenting Venographic Findings on Mid-Term Patency After Thrombectomy in

Chang Hoon Oh1, In Chul Nam2, Doo Ri Kim2

  • 1Department of Radiology, Samsung Medical Center, School of Medicine, Sungkyunkwan University, Seoul 06351, Republic of Korea.

Insights

In May-Thurner syndrome (MTS)-related iliofemoral deep vein thrombosis (DVT), residual stenosis over 50% after stenting significantly increases reocclusion risk. Achieving full vessel opening is crucial for long-term stent patency.

Area of Science:

  • Vascular Surgery
  • Interventional Radiology
  • Cardiovascular Medicine

Background:

  • May-Thurner syndrome (MTS) can lead to iliofemoral deep vein thrombosis (DVT).
  • Stent failure is a concern in MTS-related DVT treatment.
  • Predictors of stent patency in MTS-related DVT require further definition.

Purpose of the Study:

  • To evaluate stent patency outcomes in patients with MTS-related iliofemoral DVT.
  • To identify stent-related parameters influencing the risk of stent occlusion.
  • To analyze the prognostic value of immediate post-stenting venographic findings.

Main Methods:

  • Retrospective study of 50 patients with acute iliofemoral DVT secondary to MTS undergoing thrombectomy and stenting.
  • Evaluation of stent diameter, oversizing, stent type, and post-stenting stenosis as predictors of primary patency.
  • Kaplan-Meier and Cox proportional hazards analyses were performed.

Main Results:

  • Overall primary patency rates were 88% at 1 year and 81.2% at 2 years.
  • Stent occlusion occurred in 18% of patients within the first year.
  • Residual stenosis ≥50% on completion venography was a strong predictor of occlusion (HR, 4.625; p < 0.001).
  • Stent diameter, oversizing, and stent type were not significantly associated with patency.

Conclusions:

  • Thrombectomy with stenting offers excellent mid-term patency for MTS-related DVT.
  • Early stent failure is linked to residual stenosis ≥50% post-deployment.
  • Complete luminal restoration during the initial procedure is critical for long-term stent patency.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
445
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
724